KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Csx (CSX) Cash & Equivalents (2016 - 2025)

Csx (CSX) has disclosed Cash & Equivalents for 17 consecutive years, with $670.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 28.19% to $670.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $670.0 million, a 28.19% decrease, with the full-year FY2025 number at $670.0 million, down 28.19% from a year prior.
  • Cash & Equivalents was $670.0 million for Q4 2025 at Csx, up from $612.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $3.0 billion in Q2 2021 to a low of $387.0 million in Q2 2025.
  • A 5-year average of $1.5 billion and a median of $1.4 billion in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 48.12% in 2021, then crashed 75.75% in 2022.
  • Csx's Cash & Equivalents stood at $2.2 billion in 2021, then dropped by 13.67% to $1.9 billion in 2022, then crashed by 30.01% to $1.4 billion in 2023, then tumbled by 31.04% to $933.0 million in 2024, then dropped by 28.19% to $670.0 million in 2025.
  • Per Business Quant, the three most recent readings for CSX's Cash & Equivalents are $670.0 million (Q4 2025), $612.0 million (Q3 2025), and $387.0 million (Q2 2025).